Profile
Lin Hanhua holds bachelor's degrees in law and economics and has nearly ten years of experience in financial asset management. His practice focuses on investment and M&A, corporate governance, private funds, asset-management business and intellectual property.
He combines contentious and non-contentious experience with attention to commercial logic, transaction structure and risk control, providing systematic and commercially practical legal solutions. He has long served investment, financing and corporate clients and has experience spanning capital markets, governance and dispute resolution.
He currently acts as standing legal counsel to listed companies including Leader Pharmaceutical Bio-Technology (HK:0399), Huahui Education (OTC:HHEGF) and BKS (NEEQ:833908).
Representative Experience:
Provided legal due diligence for an equity investment in an intelligent-medical-technology company; advised on bankruptcy-creditor filings, financing exits and distress resolution, equity capital increases and share-swap corporate restructurings.
Advised private-fund and asset-management projects on post-investment management, disclosures, asset disposal, collection, arbitration, fund establishment, due diligence and investment documentation.
Acted in securities-misrepresentation, fund-repurchase, equity-repurchase, fund-contract and commercial-contract disputes before courts and arbitration commissions in Changchun, Guangzhou, Beijing and Zhuhai.